English | Español
Amanda Rupp | Jun 2, 2016

Imbruvica gains approval for treating chronic lymphocytic leukemia
Amanda Rupp | Jun 1, 2016

CDC's Zika surveillance provides early statistics for pregnant women

Amanda Rupp | Jun 1, 2016

Afstyla gains FDA approval as hemophilia A treatment
Amanda Rupp | Jun 1, 2016

World MS Day research to increase independence of MS patients
Amanda Rupp | Jun 1, 2016

NCHC applauds hospital readmissions policy changes
Amanda Rupp | Jun 1, 2016

CHMP gives positive opinion of Zepatier tablet
Amanda Rupp | Jun 1, 2016

FDA approves Zinbryta to treat MS
Amanda Rupp | Jun 1, 2016

FDA approves new diagnostic imaging agent for recurrent prostate cancer

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access